Clinical & Experimental Metastasis

Re-publication of: Metastases and the normalization of tumour blood vessels by ICRF 159: a new type of drug action

Actin cytoskeletal mediators of motility and invasion amplified and overexpressed in head and neck cancer

Laura C. Kelley, Sohrab Shahab, Scott A. Weed

Stepping out of the flow: capillary extravasation in cancer metastasis

Fayth L. Miles, Freddie L. Pruitt, Kenneth L. van Golen, Carlton R. Cooper

Extravasation and homing mechanisms in multiple myeloma

Isabelle Vande Broek, Karin Vanderkerken, Benjamin Van Camp, Ivan Van Riet

Selectins and selectin ligands in extravasation of cancer cells and organ selectivity of metastasis

Stéphanie Gout, Pierre-Luc Tremblay, Jacques Huot

Organ selectivity in metastasis: regulation by chemokines and their receptors

Adit Ben-Baruch

The Diasporin Pathway: a tumor progression-related transcriptional network that predicts breast cancer survival

Nigel P. S. Crawford, Renard C. Walker, Luanne Lukes, Jennifer S. Officewala, Robert W. Williams, Kent W. Hunter

Bisphosphonates for bone metastatic disease from breast cancer—clinical practice in the Czech Republic

Veronika Vokata, Karel Odrazka, Ales Kubena, Jiri Vlcek

Differential expression of angiogenesis associated genes in prostate cancer bone, liver and lymph node metastases

Colm Morrissey, Lawrence D. True, Martine P. Roudier, Ilsa M. Coleman, Sarah Hawley, Peter S. Nelson, Roger Coleman, Ya-Chun Wang, Eva Corey, Paul H. Lange, Celestia S. Higano, Robert L. Vessella

Increased COX2 expression enhances tumor-induced osteoclastic lesions in breast cancer bone metastasis

Zhigang Li, Christian Schem, Yihui H. Shi, Daniel Medina, Ming Zhang

Roles of osteoclasts and bone-derived IGFs in the survival and growth of human breast cancer cells in human adult bone implanted into nonobese diabetic/severe combined immunodeficient mice

Takafumi Sangai, Hiroshi Fujimoto, Shin’ichi Miyamoto, Hiroyuki Maeda, Michio Nakamura, Genichiro Ishii, Kanji Nagai, Takeshi Nagashima, Masaru Miyazaki, Atsushi Ochiai

Acid treatment of melanoma cells selects for invasive phenotypes

Raymond E. Moellering, Kvar C. Black, Chetan Krishnamurty, Brenda K. Baggett, Phillip Stafford, Matthew Rain, Robert A. Gatenby, Robert J. Gillies

Prognostic significance of 18F-FDG uptake in primary osteosarcoma after but not before chemotherapy: a possible association with autocrine motility factor/phosphoglucose isomerase expression

Junko Sato, Takashi Yanagawa, Yoh Dobashi, Takehiko Yamaji, Kenji Takagishi, Hideomi Watanabe

Human breast adenocarcinoma (MDA-231) and human lung squamous cell carcinoma (Hara) do not have the ability to cause bone resorption by themselves during the establishment of bone metastasis

Amy Tomita, Tatsuhiko Kasaoka, Takashi Inui, Minako Toyoshima, Hiroko Nishiyama, Hiromasa Saiki, Haruo Iguchi, Motowo Nakajima

First surgical tumour reduction of peritoneal surface malignancy in a rat’s model

Jens Hartmann, Maik Kilian, Vladimir Atanassov, Chris Braumann, Juergen Ordemann, Christoph A. Jacobi

GRP-induced up-regulation of Hsp72 promotes CD16+/94+ natural killer cell binding to colon cancer cells causing tumor cell cytolysis

Lauren Taglia, Damien Matusiak, Richard V. Benya

Serum proteome analysis for profiling protein markers associated with carcinogenesis and lymph node metastasis in nasopharyngeal carcinoma

Qiulin Liao, Liang Zhao, Xiaodong Chen, Yongjian Deng, Yanqing Ding

Targeting the EGFR, VEGFR, and PDGFR on colon cancer cells and stromal cells is required for therapy

Toshio Kuwai, Toru Nakamura, Takamitsu Sasaki, Yasuhiko Kitadai, Jang-Seong Kim, Robert R. Langley, Dominic Fan, Xuemei Wang, Kim-Anh Do, Sun-Jin Kim, Isaiah J. Fidler

Dissociated invasively growing cancer cells with NF-kappaB/p65 positivity after radiotherapy: a new marker for worse clinical outcome in rectal cancer? Preliminary data

Rene Voboril, Jana Voborilova, Vlasta Rychterova, Tomas Jirasek, Josef Dvorak